Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation

Malaria caused by Plasmodium falciparum causes numerous cases of morbidity with about 400,000 deaths yearly owing, mainly, to inflammation leading to cerebral malaria (CM). CM conventionally is treated by repetitive administration of anti-plasmodial drugs and supportive non-specific drugs, for about...

Descripción completa

Detalles Bibliográficos
Autores principales: Golenser, Jacob, Salaymeh, Nadeen, Higazi, Abd Alroof, Alyan, Mohammed, Daif, Mahran, Dzikowski, Ron, Domb, Abraham J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303303/
https://www.ncbi.nlm.nih.gov/pubmed/32595499
http://dx.doi.org/10.3389/fphar.2020.00846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303303/
https://www.ncbi.nlm.nih.gov/pubmed/32595499
http://dx.doi.org/10.3389/fphar.2020.00846

Ejemplares similares